Nicholas N. Lyssenko

877 total citations
25 papers, 633 citations indexed

About

Nicholas N. Lyssenko is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Nicholas N. Lyssenko has authored 25 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Nicholas N. Lyssenko's work include Cholesterol and Lipid Metabolism (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Nicholas N. Lyssenko is often cited by papers focused on Cholesterol and Lipid Metabolism (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Nicholas N. Lyssenko collaborates with scholars based in United States, Switzerland and Netherlands. Nicholas N. Lyssenko's co-authors include Domenico Praticò, Michael C. Phillips, Robert Schlegel, Mark L. Tucker, Catherine A. Whitelaw, Carl Hirschie Johnson, Xiaodong Xu, Byung‐Hoon Kim, Albrecht G. von Arnim and Chitra Subramanian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLANT PHYSIOLOGY.

In The Last Decade

Nicholas N. Lyssenko

24 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas N. Lyssenko United States	15	341	159	157	83	72	25	633
Feven Tameire United States	9	502 1.5×	140 0.9×	34 0.2×	80 1.0×	82 1.1×	11	847
George Talbott United States	9	792 2.3×	144 0.9×	32 0.2×	193 2.3×	82 1.1×	17	1.1k
Victor Babich United States	15	484 1.4×	42 0.3×	71 0.5×	80 1.0×	90 1.3×	29	766
Chantal Depatie Canada	10	443 1.3×	162 1.0×	22 0.1×	48 0.6×	109 1.5×	13	661
Shoko Takehara Japan	16	685 2.0×	68 0.4×	58 0.4×	149 1.8×	110 1.5×	22	878
Caroline Lefèvre France	10	705 2.1×	198 1.2×	63 0.4×	358 4.3×	38 0.5×	12	1.3k
Toby A. Dite Australia	14	643 1.9×	236 1.5×	37 0.2×	87 1.0×	50 0.7×	24	809
Anika V. Prabhu Australia	10	444 1.3×	140 0.9×	13 0.1×	67 0.8×	33 0.5×	13	732
Teresa Rubio Spain	14	266 0.8×	55 0.3×	48 0.3×	68 0.8×	34 0.5×	17	462
María‐Ángeles Navas Spain	14	557 1.6×	468 2.9×	23 0.1×	61 0.7×	55 0.8×	24	839

Countries citing papers authored by Nicholas N. Lyssenko

Since Specialization

Citations

This map shows the geographic impact of Nicholas N. Lyssenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas N. Lyssenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas N. Lyssenko more than expected).

Fields of papers citing papers by Nicholas N. Lyssenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas N. Lyssenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas N. Lyssenko. The network helps show where Nicholas N. Lyssenko may publish in the future.

Co-authorship network of co-authors of Nicholas N. Lyssenko

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas N. Lyssenko. A scholar is included among the top collaborators of Nicholas N. Lyssenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas N. Lyssenko. Nicholas N. Lyssenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Praticò, Domenico, et al.. (2024). Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOE. Journal of Neuropathology & Experimental Neurology. 83(10). 808–821. 1 indexed citations

Lyssenko, Nicholas N., et al.. (2023). Down-Regulation of ABCA7 in Human Microglia, Astrocyte and THP-1 Cell Lines by Cholesterol Depletion, IL-1β and TNFα, or PMA. Cells. 12(17). 2143–2143. 4 indexed citations

Ko, Yi-An, Jeffrey T. Billheimer, Nicholas N. Lyssenko, et al.. (2022). ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 194–194. 13 indexed citations

Filippone, Alessia, et al.. (2022). The contribution of altered neuronal autophagy to neurodegeneration. Pharmacology & Therapeutics. 238. 108178–108178. 41 indexed citations

Filippone, Alessia, et al.. (2022). The Contribution of Altered Neuronal Autophagy to Neurodegeneration. SSRN Electronic Journal.

Picataggi, Antonino, Amrith Rodrigues, Debra Cromley, et al.. (2022). Specificity of ABCA7-mediated cell lipid efflux. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867(7). 159157–159157. 11 indexed citations

Picataggi, Antonino, Jeffrey T. Billheimer, Gui‐Shuang Ying, et al.. (2020). Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer’s Disease. Journal of Alzheimer s Disease. 74(2). 563–578. 7 indexed citations

Khoshnejad, Makan, Ami Patel, Sagar B. Kudchodkar, et al.. (2018). Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics. Molecular Therapy. 27(1). 188–199. 28 indexed citations

Lyssenko, Nicholas N., Antonino Picataggi, Wanzhen Jiao, et al.. (2018). Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium. Journal of Lipid Research. 59(10). 1927–1939. 20 indexed citations

10.

Kling, Mitchel A., Jeffrey T. Billheimer, Nicholas N. Lyssenko, et al.. (2018). P3‐069: CHOLESTEROL EFFLUX CAPACITY (CEC) IN PLASMA AND CEREBROSPINAL FLUID (CSF) OF PATIENTS WITH ALZHEIMER'S DISEASE (AD) AND MILD COGNITIVE IMPAIRMENT (MCI) AND COMPARISON SUBJECTS: EFFECTS OF GENDER AND DIAGNOSIS. Alzheimer s & Dementia. 14(7S_Part_20). 1 indexed citations

11.

Bi, Xin, Evanthia Pashos, Marina Cuchel, et al.. (2017). ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion. EBioMedicine. 18. 139–145. 19 indexed citations

12.

Kuwano, Takashi, Xin Bi, Tomoyuki Yasuda, et al.. (2017). Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport. Journal of Lipid Research. 58(4). 731–741. 13 indexed citations

13.

Vitali, Cecilia, John S. Millar, Chongren Tang, et al.. (2016). Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(12). 1968–1979. 5 indexed citations

14.

Luthi, Andrea J., Nicholas N. Lyssenko, Kaylin M. McMahon, et al.. (2015). Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein. Journal of Lipid Research. 56(5). 972–985. 40 indexed citations

15.

Lund‐Katz, Sissel, Nicholas N. Lyssenko, Margaret Nickel, et al.. (2013). Mechanisms Responsible for the Compositional Heterogeneity of Nascent High Density Lipoprotein. Journal of Biological Chemistry. 288(32). 23150–23160. 32 indexed citations

16.

Lyssenko, Nicholas N., Mami Hata, Padmaja Dhanasekaran, et al.. (2011). Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821(3). 456–463. 28 indexed citations

17.

Lyssenko, Nicholas N., Yana Miteva, Simon Gilroy, Wendy Hanna‐Rose, & Robert Schlegel. (2008). An unexpectedly high degree of specialization and a widespread involvement in sterol metabolism among the C. elegans putative aminophospholipid translocases. BMC Developmental Biology. 8(1). 96–96. 23 indexed citations

18.

Neukomm, Lukas J., Steve J. Charette, Nicholas N. Lyssenko, et al.. (2007). Aminophospholipid Translocase TAT-1 Promotes Phosphatidylserine Exposure during C. elegans Apoptosis. Current Biology. 17(11). 994–999. 57 indexed citations

19.

Lyssenko, Nicholas N., Wendy Hanna‐Rose, & Robert Schlegel. (2007). Cognate Putative Nuclear Localization Signal Effects Strong Nuclear Localization of a GFP Reporter and Facilitates Gene Expression Studies in Caenorhabditis Elegans. BioTechniques. 43(5). 596–600. 23 indexed citations

20.

Tucker, Mark L., Catherine A. Whitelaw, Nicholas N. Lyssenko, & Pravendra Nath. (2002). Functional Analysis of Regulatory Elements in the Gene Promoter for an Abscission-Specific Cellulase from Bean and Isolation, Expression, and Binding Affinity of Three TGA-Type Basic Leucine Zipper Transcription Factors. PLANT PHYSIOLOGY. 130(3). 1487–1496. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact